This review highlights the increasing incidence of breast cancer, making it a major health concern for women globally. While most cases can be treated with surgery and endocrine drugs, triple-negative breast cancer (TNBC) poses a significant challenge due to limited effective treatments. Nectin-4, previously limited to specific tissues, has emerged as a potential therapeutic target. Overexpressed in breast cancer, Nectin-4 plays a crucial role in tumor formation, proliferation, and metastasis. Current treatments, including chemotherapy and targeted therapy, have limitations, necessitating new strategies. Nectin-4, identified as a breast cancer stem cell marker, holds promise for TNBC prognosis. This review provides valuable insights for researchers and clinicians, outlining potential directions for further studies and therapies.
Related Posts
Research problem: A statement of intent
A research problem is a statement based on the area of research, which is the first step in a research process. Devising an appropriate research problem depends on the in-depth knowledge, skills, and expertise of a researcher in their particular subject field. Therefore, a researcher needs to devote considerable time to select a suitable research […]
Ditch the Diab? Weighing the Pros and Cons of Metabolic Surgery for Type 2 Diabetes
For some struggling with type 2 diabetes and obesity, a drastic, yet potentially life-altering option has emerged: metabolic surgery. Procedures like gastric bypass offer significant weight loss, which research suggests can lead to diabetes remission or dramatically improve blood sugar control. However, as with any major medical decision, careful consideration of both the potential benefits […]
Multi-Omics Approach for Short-Term COVID-19 Progression Prediction in ICU Patients
The study developed a multi-omics approach to predict short-term COVID-19 progression in ICU patients. Analyzing data from 32 SARS-CoV-2-infected patients, including 124 clinical parameters, 271 proteins, and 782 metabolites/lipids, it identified CCL7, CA14 proteins, and hexosylceramide 18:2 as key markers. A machine learning model accurately forecasted worsening conditions up to five days in advance (79% […]